Espina, Zyruz Ryl M.
HRN: 29-33-14 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/16/2026
OXACILLIN 500MG (VIAL)
07/16/2026
07/23/2026
IV
320mg
Q6hours
T/c Cellulitis
Checking Final Appropriateness
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes